ADP-blodplateaggregeringsreagens — LTA-agonist (3 × 0,1 µmol)

Kun til forskningsbruk. Ikke til bruk i diagnostiske prosedyrer.

ADP reagent for Light Transmission Aggregometry (LTA) platelet function testing. 3x0.1 µmol. Primary platelet agonist. Screens for P2Y12 pathway defects (e.g., inherited P2Y12 deficiency, storage pool deficiency). Also detects GPIIb/IIIa effector defects (including Glanzmann thrombasthenia — absent aggregation to all agonists via shared GPIIb/IIIa convergence). Assesses clopidogrel (Plavix®) and ticagrelor response — ADP hyporesponsiveness suggests effective P2Y12 inhibition. CE-IVD.